AVANDIA

This brand name is authorized in United States. It is also authorized in Lithuania.

Active ingredients

The drug AVANDIA contains one active pharmaceutical ingredient (API):

1	Rosiglitazone UNII KX2339DP44 - ROSIGLITAZONE MALEATE
	Rosiglitazone is a selective agonist at the PPARγ (peroxisomal proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of anti-diabetic agents. It reduces glycaemia by reducing insulin resistance at adipose tissue, skeletal muscle and liver.
	Read more about Rosiglitazone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AVANDIA Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
AVANDIA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BG02	Rosiglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1004060, 1004061, 1008706, 1008707, 1008708, 1026578, 1026579, 1026580, 1026581, 1026582, 1026583, 1026584, 1026585, 1026586, 1026587, 1026588, 1026589, 1026590
US	FDA, National Drug Code	0173-0861, 0173-0863